Priya Oberoi

Priya Oberoi is the founding general partner of Goddess Gaia Ventures, a London-based fund she describes as Europe's first dedicated women's-health VC. GGV invests in pre-Series A companies across femtech, female fertility, female cancers, lifestyle diseases and women's wellness, with a strategy of scaling European portfolio companies into the US market.

Oberoi read Jurisprudence at Somerville College, Oxford, and spent over a decade at Clifford Chance, where she became a recognised voice in structured finance and was an architect of the ISDA-IIFM Tahawut Master Agreement, a foundational template in the Islamic derivatives industry. In 2010 she founded Oberoi Capital Partners, a boutique placement firm raising capital for funds across asset classes from GCC institutional investors.

Goddess Gaia Ventures is targeting a £100 million debut fund and has already deployed capital into 11 portfolio companies, including Holly Health and fetal heart-rate wearable Biorithm. Oberoi is a vulvar cancer survivor whose own experience navigating the healthcare system informed the fund's thesis, and she is a frequent speaker on the women's health funding gap.